Biopharmaceutical giant AbbVie has formally accelerated its strategic push into global sports marketing by announcing a multi-year partnership with the…
Read More
Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors
Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…
Read More
INmune Bio and Quantum Computing Inc. Join Forces in Milestone Partnership to Accelerate Drug Discovery for XPro Using Advanced Quantum Technology
Biotechnology innovator INmune Bio has entered into a landmark strategic partnership with Quantum Computing Inc. (QCi), marking QCi’s first-ever commercial…
Read More
Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
Pharmaceutical giant Pfizer has entered into a strategic research collaboration and licensing agreement with Enodia Therapeutics valued at upwards of…
Read More
New Molecular Partnership Discovered in Japan Sheds Light on Male Fertility and Sperm Development
The intricate architecture of the human body relies upon countless biological checks and balances designed to guarantee the precise growth,…
Read More
Eli Lilly Expands Multi-Million Dollar Biotech Partnership with Gate Bioscience to Pioneer ‘Molecular Gate’ Therapies for Hard-to-Drug Proteins
Eli Lilly and Company has significantly deepened its footprint in cutting-edge drug discovery by expanding its strategic partnership and licensing…
Read More
AstraZeneca and Daiichi Sankyo Join Forces with Summit Therapeutics in Strategic Clinical Partnership to Evaluate Novel Oncology Combinations
The oncology landscape is undergoing a significant strategic consolidation as major pharmaceutical players align their pipelines to maximize the therapeutic…
Read More
Novartis Secures Strategic Partnership with Abogen to Advance Novel T-Cell Engager Therapies in Autoimmune Disease
The landscape of pharmaceutical partnerships continues to evolve at a rapid pace, marked by strategic alliances designed to tackle complex…
Read More
Eli Lilly and InnoCare Pharma Forge $3.35bn R&D Partnership to Tackle Oncology and Autoimmune Diseases
Eli Lilly and Company has entered into a sweeping, five-drug research and licensing agreement with China-based biopharmaceutical firm InnoCare Pharma,…
Read More
Sandoz and mAbxience Forge Strategic Global Partnership to Develop and Commercialize Emicizumab Biosimilar for Haemophilia A
The global pharmaceutical landscape is undergoing a significant shift toward expanded accessibility for complex biologic therapies, highlighted by a major…
Read More
